SNCA and Parkinson disease: Mutations in genes, including LRRK2 (Leucine-Rich Repeat Kinase 2), PINK1, and SNCA (α-synuclein), help to explain mitochondrial malfunction and dopaminergic neural loss in Parkinson’s disease (PD).